The General Hospital Corporation; Inc.;Dana-Farber Cancer Institute;Dana-Farber Cancer Institute, Inc.
发明人:
Hacohen, Nir,Wu, Catherine
申请号：
AU2018206769
公开号：
AU2018206769A1
申请日:
2018.07.19
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018206769A120180809.pdf#####ABSTRACT The present invention is related to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. Specifically, the invention provides a method of identifying tumor specific neoantigens that alone or in combination with other tumor-associated peptides serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor responses.
